Market Tracker

03/04 4:45pm ET

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

1.13
Delayed Data
As of Mar 04
 0.00 / 0.00%
Today’s Change
0.91
Today|||52-Week Range
6.50
-29.38%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close1.13
Today’s open1.12
Day’s range1.11 - 1.14
Volume65,993
Average volume (3 months)212,038
Market cap$23.9M
Dividend yield--
Data as of 3:59pm ET, 03/04/2015

Growth & Valuation

Earnings growth (last year)+49.47%
Earnings growth (this year)+72.22%
Earnings growth (next 5 years)--
Revenue growth (last year)+311.34%
P/E ratioNM
Price/Sales74.60
Price/Book4.61

Competitors

 Today’s
change
Today’s
% change
CBMXCombiMatrix Corp+0.05+2.70%
GENEGenetic Technologies...+0.39+7.28%
--Cell Source Inc+0.13+14.50%
ICCCImmuCell Corp+0.12+1.74%
Data as of 3:59pm ET, 03/04/2015

Financials

Last reporting dateMarch 5, 2015
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$399.0K
Annual profit (last year)-$20.9M
Net profit margin-5,244.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Westborough, Massachusetts

Forecasts